Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD

Blood (2016) 128 (22): 3438.

https://doi.org/10.1182/blood.V128.22.3438.3438

Published: 2016

Journal Articles

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Abhinav Deol, MD, Salyka Sengsayadeth, MD, Madan Jagasia, MBBS, MS, Kwang W Ahn, PhD, Hailin Wang, MPH, Brenda M. Sandmaier, MD, Steven M. Devine, MD, Marcos de Lima, MD, Daniel J. Weisdorf, MD, Wael Saber, MD MS

Blood (2014) 124 (21): 322.

https://doi.org/10.1182/blood.V124.21.322.322

Published: 2014

Journal Articles

Impact of Different Mobilization Methods on Graft Composition and Outcome after Autologous Stem Cell Transplantation: Implications for Upfront Use of Plerixafor

LaQuisa Hill, MD, Oluchi C. Ukaegbu, MD, Bipin N. Savani, MD, Salyka Sengsayadeth, MD, Stacey Goodman, MD, Stephen J. Brandt, MD, Wichai Chinratanalab, MD

Blood (2014) 124 (21): 1125.

https://doi.org/10.1182/blood.V124.21.1125.1125

Published: 2014

Journal Articles

Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant

Mirat Shah, MD, Bridget Ory Dickerson, MD, Bipin N. Savani, MD, Lora Thomas, MD, Wichai Chinratanalab, MD, Brian Engelhardt, MD, Stacey Goodman, MD, John P Greer, MD, Adetola A. Kassim, MD, Salyka Sengsayadeth, MD, Madan Jagasia, MBBS, MS

Blood (2014) 124 (21): 3868.

https://doi.org/10.1182/blood.V124.21.3868.3868

Published: 2014

Journal Articles

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Salyka Sengsayadeth, MD, Tao Wang, PhD, Stephanie J. Lee, MD, MPH, Michael D. Haagenson, MS, Stephen Spellman, MBS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS

Blood (2013) 122 (21): 710.

https://doi.org/10.1182/blood.V122.21.710.710

Published: 2013

NARROW

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Impact of Different Mobilization Methods on Graft Composition and Outcome after Autologous Stem Cell Transplantation: Implications for Upfront Use of Plerixafor

Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Email alerts

ASH Publications

American Society of Hematology

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Impact of Different Mobilization Methods on Graft Composition and Outcome after Autologous Stem Cell Transplantation: Implications for Upfront Use of Plerixafor

Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only